Oakbrook Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,800
| Closed | -$1.32M | – | 627 |
|
|
2019
Q3 | $1.32M | Buy |
+7,800
| New | +$1.32M | 0.09% | 173 |
|
|
2019
Q1 | – | Sell |
-9,425
| Closed | -$1.56M | – | 645 |
|
|
2018
Q4 | $1.56M | Sell |
9,425
-7,675
| -45% | -$1.27M | 0.11% | 145 |
|
|
2018
Q3 | $3.3M | Sell |
17,100
-275
| -2% | -$53K | 0.18% | 90 |
|
|
2018
Q2 | $2.95M | Sell |
17,375
-645
| -4% | -$110K | 0.19% | 87 |
|
|
2018
Q1 | $2.94M | Buy |
18,020
+1,625
| +10% | +$265K | 0.18% | 89 |
|
|
2017
Q4 | $2.46M | Sell |
16,395
-4,380
| -21% | -$656K | 0.16% | 99 |
|
|
2017
Q3 | $3.16M | Buy |
20,775
+1,050
| +5% | +$160K | 0.2% | 89 |
|
|
2017
Q2 | $2.54M | Buy |
+19,725
| New | +$2.54M | 0.17% | 110 |
|
|
2016
Q2 | – | Sell |
-24,220
| Closed | -$1.93M | – | 593 |
|
|
2016
Q1 | $1.93M | Buy |
24,220
+10,000
| +70% | +$795K | 0.12% | 146 |
|
|
2015
Q4 | $1.79M | Sell |
14,220
-6,430
| -31% | -$809K | 0.11% | 155 |
|
|
2015
Q3 | $2.15M | Buy |
20,650
+350
| +2% | +$36.4K | 0.14% | 139 |
|
|
2015
Q2 | $2.51M | Sell |
20,300
-9,975
| -33% | -$1.23M | 0.15% | 136 |
|
|
2015
Q1 | $3.57M | Buy |
30,275
+12,275
| +68% | +$1.45M | 0.19% | 122 |
|
|
2014
Q4 | $2.14M | Sell |
18,000
-19,350
| -52% | -$2.3M | 0.12% | 167 |
|
|
2014
Q3 | $4.2M | Sell |
37,350
-27,203
| -42% | -$3.06M | 0.23% | 106 |
|
|
2014
Q2 | $6.11M | Sell |
64,553
-9,150
| -12% | -$866K | 0.18% | 135 |
|
|
2014
Q1 | $5.21M | Sell |
73,703
-7,950
| -10% | -$562K | 0.16% | 144 |
|
|
2013
Q4 | $6.07M | Sell |
81,653
-7,550
| -8% | -$561K | 0.17% | 141 |
|
|
2013
Q3 | $6.76M | Buy |
89,203
+67,250
| +306% | +$5.1M | 0.2% | 123 |
|
|
2013
Q2 | $1.76M | Buy |
+21,953
| New | +$1.76M | 0.05% | 302 |
|